Brief: Citius Oncology Prices $9M Direct Offering & Private Placement
09/09/2025 13:37
Sept 9 (Reuters) - Citius Oncology Inc CTOR.O: CITIUS ONCOLOGY ANNOUNCES PRICING OF $9.0 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT CITIUS ONCOLOGY INC - OFFERING PRICE FOR SHARE AND WARRANT IS $1.75 Source text: ID:nPn63dctLa Further company coverage: CTOR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Citius Pharmaceuticals
See all newsCitius Pharmaceuticals Q2 revenue rises on LYMPHIR launch
Citius Pharmaceuticals reports first revenue of $3.9 mln
Brief: Citius Oncology Expands International Distribution Of Lymphir™ To European Union Through Exclusive Agreement With Uniphar
Brief: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results And Provides Business Update
Brief: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering And Private Placement Priced At-The-Market Under Nasdaq Rules